UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005857 |
|---|---|
| Receipt number | R000006919 |
| Scientific Title | Phase II Study to Evaluate Efficacy and Safety of Capecitabine + Cisplatin Combination Therapy in Gastric Cancer Patients Who Relapsed After S-1 Adjuvant Chemotherapy |
| Date of disclosure of the study information | 2011/06/30 |
| Last modified on | 2019/01/10 16:25:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/06/27 17:20:11 | ||
| 2 | Update | 2011/06/28 15:33:37 | Narrative objectives1 |
|
| 3 | Update | 2011/06/28 15:40:56 | Key inclusion criteria Key exclusion criteria |
|
| 4 | Update | 2011/08/16 16:50:22 | Recruitment status |
|
| 5 | Update | 2011/08/16 17:24:22 | Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
| 6 | Update | 2012/06/27 09:51:46 | Email1 |
|
| 7 | Update | 2014/10/15 17:26:22 | TEL Last name of contact person Last name of contact person TEL |
|
| 8 | Update | 2014/10/15 18:09:38 | Recruitment status |
|
| 9 | Update | 2015/12/28 10:20:40 | Last follow-up date |
|
| 10 | Update | 2019/01/10 15:48:28 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2019/01/10 16:05:15 | Recruitment status Publication of results URL related to results and publications Results Results |
|
| 12 | Update | 2019/01/10 16:25:54 | URL related to results and publications Results Results |
